Jamie Hoang
Medical · Tucson, AZNPI 1760107932
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by UCB, Inc. at 26.6% of the total. 2025 is the largest year on record at $2,377, more than ten times the $33 reported in 2023.
Across 181 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- AbbVie$954
- Amgen$523
- Pfizer$193
- Organon$169
- Radius Health, Inc.$131
- plus $891 from 21 others
What the payments were for
- Food & beverage$3,901100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 35 | $1,038 |
| AbbVie | 43 | $954 |
| Amgen | 36 | $523 |
| Pfizer | 11 | $193 |
| Organon | 9 | $169 |
| Radius Health, Inc. | 6 | $131 |
| Mallinckrodt Hospital Products Inc. | 5 | $126 |
| Fresenius Kabi USA, LLC | 5 | $121 |
| AstraZeneca | 6 | $102 |
| Octapharma USA, Inc. | 2 | $75 |
| Johnson & Johnson | 4 | $72 |
| Sanofi | 2 | $48 |
| Celltrion USA Inc. | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| DJO, LLC | 1 | $33 |
| Novartis | 1 | $31 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Biocon Biologics Inc | 1 | $23 |
| Almatica Pharma LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Aurinia Pharma U.S., Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Sandoz | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| ANI Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$125
How this compares
$3,901 in reported general payments places this provider in the 80th percentile of 748 medical providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 50 | $1,763 |
| Gabapentin | 70 | $1,635 |
| Leflunomide | 20 | $1,189 |
| Prednisone | 163 | $963 |
| Duloxetine Hcl | 60 | $864 |
| MethotrexateMethotrexate Sodium | 41 | $861 |
| Sulfasalazine | 18 | $389 |
| Nabumetone | 19 | $382 |
| Diclofenac Sodium | 16 | $276 |
| Methylprednisolone | 14 | $204 |
| Meloxicam | 44 | $146 |
Paid to pharmacies, not to this prescriber.
Other medical in Tucson
- Linda MoorsTucson$122K
- Danielle WergeTucson$27K
- Darek AndersonTucson$10K
- Carlos AguilarTucson$8K
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
- Scott LightfootPhoenix$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.